Recurrent Clostridium Difficile Colitis in Elderly: The Role of Fidaxomicin

Clinical Management Issues - Italy
doi 10.7175/cmi.v8i1s.954
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Seed SRL

Related search

Fidaxomicin in the Treatment of Colitis Due to Clostridium Difficile: Preliminary Results

Clinical Management Issues
MedicineAccountingManagementBusiness
2014English

Fidaxomicin for Clostridium Difficile-Associated Diarrhoea

Clinical Drug Investigation
MedicinePharmacology
2012English

Recurrent Clostridium Difficile Colitis in Cystic Fibrosis: An Emerging Problem

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2013English

Current and Emerging Management Options for Clostridium Difficile Infection: What Is the Role of Fidaxomicin?

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Fidaxomicin Use and Clinical Outcomes for Clostridium Difficile–Associated Diarrhea

Infectious Diseases in Clinical Practice
Infectious DiseasesMicrobiology
2015English

Economic Evaluation of Fidaxomicin Compared With Vancomycin in the Treatment of Clostridium Difficile Infection

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Blastocystissp. Infection Mimicking Clostridium Difficile Colitis

Case Reports in Infectious Diseases
2016English

Fatal Pseudomembranous Colitis Despite Eradication of Clostridium Difficile.

BMJ
1981English

Clostridium Difficile Infection in Elderly Nursing Home Residents

Anaerobe
Infectious DiseasesMicrobiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy